Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in the plasma membrane of human brain tumors

Cancer Letters

Volumn 132, Issue 1-2, 1998, Pages 17-21

  Kokoglu E ^a   Tuter Y ^a   Sandikci K S ^a   Yazici, Z ^a   Ulakoglu E Z ^a   Sonmez H ^a   Ozyurt E ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Arachidonic acid; Human brain tumors; Prostaglandin E2

Indexed keywords

ARACHIDONIC ACID; PROSTAGLANDIN E2;

ARTICLE; BRAIN TUMOR; CAPILLARY GAS CHROMATOGRAPHY; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOMA; HUMAN; HUMAN TISSUE; LYMPHOCYTE; MENINGIOMA; PRIORITY JOURNAL; TUMOR GROWTH; COMPARATIVE STUDY; MEDULLOBLASTOMA; METABOLISM; NEURILEMOMA; PATHOLOGY;

ARACHIDONIC ACID; BRAIN NEOPLASMS; CELL MEMBRANE; DINOPROSTONE; GLIOMA; HUMANS; MEDULLOBLASTOMA; MENINGIOMA; NEURILEMMOMA;

EID: 0032561076     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00127-X     Document Type: Article

References (33)

1. 2 as possible mediators of peritumoral brain edema. Adv. Neurosurg. 16:1988;243-249.
2. Applegate K.R., Glomset J.A. Computer based modeling of the conformation and packing properties of docosahexaenoic acid. J. Lipid Res. 27:1986;658-680.
3. Atkins D., Greaves M., Ibbotson K.J., Martin T.J. Role of prostaglandins in bone metabolism: a review. J. R. Soc. Med. 72:1979;27-34.
4. Bhakoo K.K., Crockard H.A., Lascelles P.C., Avery S.F. Prostaglandin synthesis and oedema formation during reperfusion following experimental brain ischemia in the gerbil. Stroke. 15:1984;891-895.
5. Broitman S.A., Vitale J.J., Vavrousek-Jakuba E., Gottlieb L.S. Polyunsaturated fat, cholesterol and large bowel tumorigenesis. Cancer. 40:1977;2455-2460.
6. Constantini S., Tamir J., Gomori M.J., Shohami E. Tumor prostaglandin levels correlate with edema around supratentorial meningiomas. Neurosurgery. 33(2):1993;204-211.
7. Cooper C., Jones H.G., Weller R.O., Walker V. Production of prostaglandins and thromboxane by isolated cells from intracranial tumours. J. Neurol. Neurosurg. Psychiatry. 47:1984;579-584.
8. 2 receptor in mammary tumor metastasis. Cancer Res. 51:1991;2047-2050.
9. Fulton A.M. The role of eicosanoids in tumor metastasis. Prostaglandins Leukotrienes Essential Fatty Acids. 34:1988;229-237.
10. Fulton A.M., Heppner G.H. Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas. Cancer Res. 45:1985;4779-4784.
11. Gaetani, 'Ex vivo' release of eicosanoid from human brain tissue: its relevance in the development of brain edema. Neurosurgery, 28 (6) (1991) 853-858.
12. Goodwin J.S. Prostaglandin synthetase inhibitors as immunoadjuvants in the treatment of cancer. J. Immunopharmacol. 2:1980;397-424.
13. Hanai T., Hashimoto T., Nishiwaki K., Ono M., Akomo Y., Tanaka M., Mizuno I., Yura J. Comparison of prostanoids and their precursor fatty acids in human hepatocellular carcinoma and carcinoma and noncancerous reference tissues. J. Surg. Res. 54:1993;57-60.
14. Ianotti F., Crockard A., Ladds G., Symon L. Are prostaglandins involved in experimental ischemic edema in gerbils? Stroke. 12:1981;301-306.
15. Jessup J.M., Legrue S.J., Kahan B.D., Pellis N.R. Induction of suppressor cells by a tumor-derived suppressor factor. Cell Immunol. 93:1985;9-25.
16. Klapan I., Katic V., Culo F., Cuk V. Prognostic significance of plasma prostaglandin E concentration in patients with head and neck cancer. J. Cancer Res. Clin. Oncol. 118:1992;308-313.
17. Koide T., Gotoh O., Asano T., Takakura K. Alterations of the eicosanoid synthetic capacity of rat brain microvessels following ischemia: relevance to ischemic brain edema. J. Neurochem. 44:1985;85-93.
18. Koizumi K., Ito Y., Kozima K., Fuji T. Isolation and characterization of the plasma membranes from rat ascites hepatomas and from normal rat livers, including newborn, regenerating and adult livers. J. Biochem. 79:1976;739-748.
19. Levine L. Arachidonic acid transformation and tumor production. Adv. Cancer Res. 35:1981;49-79.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265.
21. Mc lemore T.L., Hubbard W.C., Litterst C.L., Liu M.C., Miller S., Mc Mahon N.A., Eggleston J.C., Boyd M.R. Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. Cancer Res. 48:1988;3140-3147.
22. Moore S.A., Yoder E., Murphy S., Dutton G.R., Spector A.A. Astrocytes, not neurons, produce docosahexaenoic acid and arachidonic acid. J. Neurochem. 56:1991;518-524.
23. Nakazawa I., Iwaizumi M., Ohuchi K. Some features in prostaglandin synthesis of the cancer cells which metastasized into liver from intestinal cancer lesions. Tohoku J. Exp. Med. 170:1993;131-133.
24. Pickard J.D. Role of prostaglandin and arachidonic acid derivatives in the coupling of cerebral blood flow to cerebral metabolism. J. Cereb. Blood Flow Metabol. 1:1981;361-384.
25. Rigas B., Goldman I.S., Levine L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122(5):1993;518-523.
26. 2 is activated after experimental closed head injury in the rat. J. Neurochem. 53(5):1989;1541-1546.
27. Spector A.A., Burns C.P. Biological and therapeutic potential of membrane lipid modification in tumors. Cancer Res. 47:1987;4529-4537.
28. J.N. Walton, Rev. Brain's Diseases of the Nervous System, eighth ed., Oxford University Press, Oxford, 1977, pp. 239-240.
29. Wiltrout R.H., Herberman R.B., Zhang S.R., Chirigos M.A., Ortaldo J.R., Grenn K.M. Jr., Talmadge J.E. Role of organ-associated NK cell in decreased formation of experimental metastases in lung and liver. J. Immunol. 134:1985;4267-4275.
30. Wolfe L. Eicosanoids: prostaglandins, thromboxanes, leukotrienes, and other derivates of carbon-20 unsaturated fatty acids. J. Neurochem. 38:1987;1-14.
31. Yamaguchi A., Ishida T., Nishimura G., Katoh M., Miyazaki I. Investigation of colonic prostaglandins in carcinogenesis in the rat colon. Dis. Colon Rectum. 34(7):1991;572-576.
32. 2 carcinoma cell growth in culture by calcium, calmodulin and prostaglandins. Cancer Res. 45:1985;398-405.
33. Young M.R., Wheeler E., Newby M. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis carcinoma. J. Natl. Cancer Inst. 76:1986;745-750.